The anti-tumor molecular mechanisms of non-steroid anti-inflammatory drugs

Chinese Pharmacological Bulletin

Volumn 21, Issue 5, 2005, Pages 527-531

  Ren, Xian Da ^a   Lü, Yan Qing ^a   Ye, Kai He ^a   Cai, Shao Hui ^a   Ye, Chun Ling ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Cyclooxygenase; Neoplasm; Non steroid anti inflammatory drugs; Peroxisome proliferator activated receptor

Indexed keywords

CYCLOOXYGENASE 2; CYCLOPENTENONE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL PROLIFERATION; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PROSTAGLANDIN SYNTHESIS; REVIEW; TUMOR VASCULARIZATION;

EID: 23444461020     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Greenberg ER, Baron JA. Aspirin and other non-steroid anti-inflammatory drugs as cancer-preventive agents[J]. IARC Sci Publ, 1996, 139(1):91-8.
2. Li HL, Chen DD, Li XH et al. Changes in NF-κB, p53, Bcl-2 and caspase on apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: the role of reactive oxygen species[J]. Word J Gastroenterol, 2002, 8(3):431-5.
3. Li HL, Zhang HW, Chen DD et al. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells[J]. Acta Pharmacol Sin, 2002, 23(7):631-8.
4. Li XH, Li JJ, Zhang HW et al. Nimesulide inhibits tumor growth in mice implanted hepatoma: Overepression of Bax over Bcl-2.[J]. Acta Pharmacol Sin, 2003, 24(10):1045-50.
5. Li HX, Li XK, Cai SH et al. Synergistic effects of nimesuli de and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice[J]. World J Gastroentero, 2003, 9(5):936-40.
6. Na HK, Surh YJ. Peroxisome proliferator-activated receptor γ (PPARγ). Ligands as bifunctional regulators of cell proliferation [J]. Biochem Pharmacol, 2003, 66(2):1381-91.
7. Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer[J]. J Cell Physiol, 2002, 190(2):279-86.
8. Andrzej S, Michael K. Inhibition of angiogenesis by NSAIDs: Molecular mechanisms and clinical implications[J]. J Mol Med, 2003, 81(1):27 -37.
9. Li HL, Chen DD, Li XH et al. JTE-522-induced apoptosis in human gastric adenocarcinoma cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of membrane potential[J]. Word J Gastroentero, 2002, 8(2):217-23.
10. Straus DS, Glass CK. Cyclopentenone prostaglandins: New insights on biological activities and cellular targets[J]. Med Res Rev, 2001, 21(2):185-210.
11. 2 and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor γ-independent mechanisms involving reactive oxygenated species[J]. J Biol Chem, 2002, 277(33):29681-5.
12. Goetze S, Bungestock A, Crupalla C et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPAR-γ-ligands[J]. Hypertension, 2002, 40(5):748-54.
13. Van Der Woude CJ, Kleibeuker JH, Jansen PLM, Moshage H. Chronic inflammation, apoptosis and (pre-) malignant lesions in the gastro-intestinal tract[J]. Apoptosis, 2004, 9(2):123-30.
14. 2 inhibits multiple steps in the NF-κB signaling pathway[J]. Proc Natl Acad Sci USA, 2000, 97(9):4844-9.
15. Pang L, Nie M, Corbett L, Knox AJ. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptor[J]. J Immunol, 2003, 170(2):1043-51.
16. Elder DJ, Halton DE, Playle LC, Paraskeva C. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis ang induced COX-2 protein expression in colorectal carcinoma cells [J]. Int J Cancer, 2002, 99(2):323-7.
17. Gilroy DW, Colville-Nash PR. New insights into the role of COX-2 in inflammation[J]. J Mol Med, 2000, 78(1):121-9.
18. Choy H, Milas L. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: A rational advance[J]? J Natl Cancer Inst, 2003, 95(19):1440-52.
19. Totzke G, Schulze-Osthoff K, Janicke RU. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to deasth receptor-induced apoptosis independently of COX-2 inhibition[J]. Oncogene, 2003, 22(39):8021-30.
20. Ozes ON, Mayo LD. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase[J]. Nature, 1999, 401 (1):82-5.